Matthew Iverson
About Matthew Iverson
Matthew Iverson serves as the Vice President of Clinical at KalVista Pharmaceuticals, Inc., a position he has held since 2020. He holds a BS in Chemistry and an MPH from the University of Utah, and has previously worked in various leadership roles in the pharmaceutical industry.
Work at KalVista Pharmaceuticals
Matthew Iverson has served as Vice President of Clinical at KalVista Pharmaceuticals, Inc. since 2020. His role involves overseeing clinical development strategies and ensuring the successful progression of clinical trials. KalVista Pharmaceuticals is located in the Salt Lake City Metropolitan Area, where Iverson contributes to advancing the company's pipeline of innovative therapies.
Education and Expertise
Matthew Iverson holds a Bachelor of Science degree in Chemistry from the University of Utah, which he completed from 1994 to 2000. He furthered his education by obtaining a Master of Public Health (MPH) from the University of Utah School of Medicine, studying from 2006 to 2008. His educational background provides a strong foundation for his expertise in clinical development and project management.
Previous Experience in Clinical Management
Before joining KalVista Pharmaceuticals, Iverson held several key positions in clinical management. He worked at PRA International as Vice President for a brief period in 2014. Prior to that, he spent three years at ZARS Pharma, where he served as Director of Clinical Projects from 2003 to 2006 and later as Director of Project Management from 2006 to 2009. These roles equipped him with extensive experience in managing clinical trials and project oversight.
Professional Background
Matthew Iverson's professional background includes significant experience in the pharmaceutical and clinical research sectors. His career trajectory showcases a progression from clinical project management to executive leadership roles. His time at ZARS Pharma and PRA International contributed to his development as a clinical expert, preparing him for his current responsibilities at KalVista Pharmaceuticals.